Ursina Haltinner

Title: Ursina Haltinner: Innovator in Extracorporeal Treatment Technologies

Introduction

Ursina Haltinner is a notable inventor based in Niederlenz, Switzerland. She has made significant contributions to the field of medical technology, particularly in the treatment of sepsis through innovative methods. Her work focuses on improving patient outcomes by enhancing the efficacy of extracorporeal treatments.

Latest Patents

Ursina Haltinner holds a patent for an "Assembly for extracorporeal treatment of body fluids." This invention outlines a method for treating body fluids of patients suffering from sepsis. The process involves removing harmful substances from the patient's body fluid using a first mixture that contains functionalized magnetic particles. These particles are bound to a binding agent that targets specific molecules in the body fluid. The method includes a series of steps: injecting the mixture, mixing, and separating to reduce the concentration of target molecules effectively.

Career Highlights

Ursina is associated with Hemotune AG, a company dedicated to advancing medical technologies. Her role at Hemotune AG allows her to apply her innovative ideas in a practical setting, contributing to the development of life-saving treatments.

Collaborations

Ursina collaborates with talented professionals in her field, including Lukas Langenegger and Carlos Mora. Their combined expertise fosters a creative environment that drives innovation in medical technology.

Conclusion

Ursina Haltinner's work exemplifies the impact of innovation in healthcare. Her patent for extracorporeal treatment methods showcases her commitment to improving patient care and advancing medical technology.